These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 8701927

  • 1. DNA ploidy, cell cycle kinetics, and low versus high grade atypia in endometrial hyperplasia.
    Michael H, Kotylo PK, Mohr M, Roth LM.
    Am J Clin Pathol; 1996 Jul; 106(1):22-8. PubMed ID: 8701927
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Flow cytometric DNA analysis of abnormal endometrium.
    Sato S, Tanoguchi K, Tase T, Yajima A.
    Tohoku J Exp Med; 1996 Feb; 178(2):199-202. PubMed ID: 8727701
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma.
    Henderson GS, Brown KA, Perkins SL, Abbott TM, Clayton F.
    Mod Pathol; 1996 Apr; 9(4):430-8. PubMed ID: 8729985
    [Abstract] [Full Text] [Related]

  • 10. Potential of the learning vector quantizer in the cell classification of endometrial lesions in postmenopausal women.
    Karakitsos P, Kyroudes A, Pouliakis A, Stergiou EB, Voulgaris Z, Kittas C.
    Anal Quant Cytol Histol; 2002 Feb; 24(1):30-8. PubMed ID: 11865947
    [Abstract] [Full Text] [Related]

  • 11. DNA ploidy, cell proliferation and steroid hormone receptors in endometrial hyperplasia and early adenocarcinoma.
    Punnonen R, Mattila J, Kuoppala T, Koivula T.
    J Cancer Res Clin Oncol; 1993 Feb; 119(7):426-9. PubMed ID: 8491764
    [Abstract] [Full Text] [Related]

  • 12. [Flow cytometric DNA analysis of uterine endometrial carcinoma].
    Izumi S, Yamaoka K, Arai H, Watanabe T, Tsutsui F, Tamura S, Nozawa S, Kurihara S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):722-8. PubMed ID: 1890350
    [Abstract] [Full Text] [Related]

  • 13. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C, Dallenbach-Hellweg G, Schmidt D, Baehring J, Bielau S, von Knebel Doeberitz M, Gebert J.
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
    Socolov D, Socolov R, Lupascu IA, Rugina V, Gabia O, Garauleanu DM, Carauleanu A.
    Rev Med Chir Soc Med Nat Iasi; 2016 Jan; 120(2):355-62. PubMed ID: 27483717
    [Abstract] [Full Text] [Related]

  • 19. DNA-flow-cytometric measurements on the normal, atrophic, hyperplastic and neoplastic human endometrium.
    Feichter GE, Höffken H, Heep J, Haag D, Heberling D, Brandt H, Rummel H, Goerttler K.
    Virchows Arch A Pathol Anat Histopathol; 1982 Jan; 398(1):53-65. PubMed ID: 6819702
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.